Texas A&M scientists developed a nasal spray that restored memory and cognitive function for months after just two doses in animal studies, targeting brain inflammation linked to aging. The treatment was designed to deliver compounds directly to the brain through nasal pathways that bypass some barriers limiting conventional drug absorption.
Researchers focused on calming inflammatory processes in the brain that contribute to cognitive decline rather than attempting to remove individual pathological proteins associated with dementia. Animal models showed sustained behavioral improvements on memory tasks following the two-dose regimen administered through the nasal route.
Nasal delivery offers potential advantages for neurological treatments because it can transport molecules toward the central nervous system more efficiently than oral medications that face metabolic breakdown in the digestive tract. The approach remains experimental and has not been tested in human clinical trials.
Neuroscience teams cautioned that animal results frequently fail to replicate in human patients due to differences in brain complexity and disease progression. The Texas A&M work nonetheless attracted attention as a potentially low-intervention strategy for addressing age-related cognitive decline if safety and efficacy can be established in subsequent research phases.
Translating nasal drug delivery from animal models to human patients requires careful dosing studies and monitoring for off-target effects in neurological tissues. Texas A&M researchers plan additional experiments to characterize how long cognitive benefits persist and whether repeated administration produces comparable results without adverse immune responses in treated subjects.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/top/health/